Synergy for staphylococcal septicemia

Staphylococcal septicemia is a severe, life-threatening systemic infection caused by the dissemination of *Staphylococcus* species—most notably *Staphylococcus aureus*—into the bloodstream The condition affects the cardiovascular and multi-organ systems across pediatric and adult populations, triggering dysregulated host inflammatory cascades, endothelial dysfunction, and potential progression to septic shock or metastatic seeding (such as endocarditis or osteomyelitis) In antimicrobial pharmaco...

Staphylococcal septicemia is a severe, life-threatening systemic infection caused by the dissemination of *Staphylococcus* species—most notably *Staphylococcus aureus*—into the bloodstream The condition affects the cardiovascular and multi-organ systems across pediatric and adult populations, triggering dysregulated host inflammatory cascades, endothelial dysfunction, and potential progression to septic shock or metastatic seeding (such as endocarditis or osteomyelitis)

The condition affects the cardiovascular and multi-organ systems across pediatric and adult populations, triggering dysregulated host inflammatory cascades, endothelial dysfunction, and potential progression to septic shock or metastatic seeding (such as endocarditis or osteomyelitis)

In antimicrobial pharmacology, the phrase refers to the adjunctive use of an agent to achieve a synergistic bactericidal effect—classically combining a cell-wall-active drug with an aminoglycoside—to enhance pathogen clearance in invasive, high-inoculum, or refractory bloodstream infections

In antimicrobial pharmacology, the phrase refers to the adjunctive use of an agent to achieve a synergistic bactericidal effect—classically combining a cell-wall-active drug with an aminoglycoside—to enhance pathogen clearance in invasive, high-inoculum, or refractory bloodstream infections